The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKakuzi Regulatory News (KAKU)

Share Price Information for Kakuzi (KAKU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 92.50
High: 0.00
Low: 0.00
Prev. Close: 92.50
KAKU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Annual Financial Report

19 Mar 2021 07:00

RNS Number : 7888S
Kakuzi Ld
19 March 2021
 

KAKUZI PLC

 

 

ANNOUNCEMENT OF GROUP RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020

 

Summarised Consolidated Statement of Profit or Loss and other Comprehensive Income

31 December 2020

31 December 2019

Shs'000

Shs'000

Sales

3,608,941

2,888,662

Profit before fair value gain in non-current biological assets and income tax

789,719

931,063

Fair value gain in non-current biological assets

57,813

83,414

Profit before income tax

847,532

1,014,477

Income tax expense

(225,498

)

(301,038

)

Profit for the year

622,034

713,439

  Other Comprehensive Income:

Items that are not reclassified to profit or loss:

Remeasurement of post-employment benefit obligations (net of tax)

490

11,810

Total comprehensive income

622,524

725,249

Shs

Shs

Earnings per share:

Basic and diluted earnings per ordinary share

31.74

36.40

 

Summarised Consolidated Statement of Financial Position

31 December 2020

31 December 2019

Shs'000

Shs'000

EQUITY

Share capital

98,000

98,000

Other reserves

31,953

31,463

Retained earnings

5,083,696

4,814,462

Proposed dividends

352,800

274,400

Total equity

5,566,449

5,218,325

Non-current liabilities

1,080,470

1,007,047

6,646,919

6,225,372

REPRESENTED BY

Non-current assets

3,990,042

3,868,015

Current assets

1,246,650

896,890

Cash and cash balances

1,670,124

1,696,130

Current liabilities

(259,897)

(235,663)

Net current assets

2,656,877

2,357,357

6,646,919

6,225,372

 

Summarised Consolidated Statement of Cash flows

31 December 2020

31 December 2019

Shs'000

Shs'000

Cash and cash equivalents at the beginning of the year

1,696,130

1,500,935

Net cash generated from operating activities

541,255

785,578

Net cash used in investing activities

(358,206

)

(406,500

)

Net cash used in financing activities

(274,413

)

(176,400

)

Net exchange gains/(losses) on foreign currency cash & cash equivalent

65,358

(7,483

)

 (Decrease)/increase in cash and cash equivalents

(26,006

)

195,195

Cash and cash equivalents at the end of the year

1,670,124

1,696,130

 

 

 

Summarised Consolidated Statement of Changes in Equity

Share

capital

Other reserves

Retained earnings

Proposed dividends

Total

Equity

Shs'000

Shs'000

Shs'000

Shs'000

Shs'000

At 1.1.2020

98,000

31,463

4,814,462

274,400

5,218,325

Profit for the year

-

490

622,034

-

622,524

Dividends - final for 2019

-

-

-

(274,400)

(274,400)

Proposed for 2020

-

-

(352,800)

352,800

-

At 31.12.2020

98,000

31,953

5,083,696

352,800

5,566,449

 

OVERVIEW:

 

The Company achieved robust results for the year, despite the uncertainty in our main sales markets caused by the COVID-19 Pandemic, with a pre-tax profit of Shs 848 million against Shs 1,014 million last year. Both avocado and macadamia export volumes were higher than 2019 but these were not sufficient to mitigate a significant reduction of 34% in the price of avocados. The market prices in 2019 were at record levels whilst 2020's prices were more in line with medium term average. The contribution to the overall results by macadamia and sales of wood products was encouraging and reflects the benefits of having a diversified product portfolio. The significant increase in tea production in Kenya (569 million kg v 458 million kg in 2019) has impacted negatively on price levels and consequently the profitability for this crop.

The results also include the cost of the Company defending itself from a UK law firm who wished to bring Kakuzi into the jurisdiction of the United Kingdom. As previously announced, Kakuzi was dropped as a party to the UK proceedings in July 2020.

 

DIVIDEND:

The Directors recommend the payment of a first and final dividend for the financial year 2020 of Shs 18.00 per ordinary share (2019: Shs 14.00) subject to shareholders' approval. The dividend shall be paid on or about 30 June 2020 to the shareholders on the members' register at the close of business on Monday, 31 May 2021.

The summarised consolidated financial results do not include all of the disclosures required for full financial statements and should be read in conjunction with the Annual Report and consolidated financial statements for the year ended 31 December 2020. 

 

ANNUAL GENERAL MEETING:

The Annual General Meeting of the Company will be held on Tuesday,18 May 2021 at 12.00 Noon by electronic means.

 

BY ORDER OF THE BOARD

 

NICHOLAS NG'ANG'A

CHAIRMAN

18 MARCH 2021

 

 

Deloitte●

Deloitte & Touche

Certified Public Accountants (Kenya) Deloitte Place

Waiyaki Way, Muthangari

P.O. Box 40092 - GPO 00100 Nairobi

Kenya

Tel: +254 (0) 20 423 0000

Cell: +254 (0) 719 039 000 Dropping Zone No.92

Email: admin@deloitte.co.ke www.deloitte.com

 

Tel: +254 (0) 20 423 0000

Cell: +254 (0) 719 039 000 Dropping Zone No.92

Email: admin@deloitte.co.ke www.deloitte.com

 

 

INDEPENDENT AUDITORS' REPORT ON THE SUMMARISED COSOLIDATED FINANCIAL STATEMENTS

TO THE SHAREHOLDERS OF KAKUZI PLC

 

Opinion

 

The accompanying summarised consolidated financial statements of Kakuzi Plc and its subsidiaries (the "Group"), which comprise the summarised consolidated statement of financial position as at 31 December 2020, the summarised consolidated statement of profit or loss and other comprehensive income, the summarised consolidated statement of changes in equity and the summarised consolidated statement of cash flows for the year then ended, are derived from the audited financial statements of the Group for the year ended 31 December 2020.

 

In our opinion, the accompanying summarised consolidated financial statements are consistent, in all material respects, with the audited consolidated financial statements of the Group, in accordance with the requirements of the Capital Markets (Securities) (Public Offers, Listings and Disclosures) Regulation, 2002 (''the Regulations'') as applicable to summary financial statements.

 

Summarised consolidated financial Statements

 

The summarised consolidated financial statements do not contain all the disclosures required by International Financial Reporting Standards as applicable to annual financial statements. Reading the summarised consolidated financial statements and the auditors' report thereon, therefore, is not a substitute for reading the audited consolidated financial statements of the Group and the auditors' report thereon.

 

The audited financial statements and our report thereon

 

We expressed an unmodified audit opinion on the audited consolidated financial statements in our report dated 18 March 2021. That report also includes the communication of a key audit matter.

 

Directors' responsibility for the summarised consolidated financial statements

 

The Directors are responsible for the preparation of the summarised consolidated financial statements in accordance with the requirements of the Capital Markets (Securities) (Public Offers, Listings and Disclosures) Regulation, 2002 Requirements as applicable to summarised financial statements.

 

Auditors' responsibility

 

Our responsibility is to express an opinion on whether the summarised consolidated financial statements are consistent, in all material respects, with the audited consolidated financial statements based on our procedures, which were conducted in accordance with International Standard on Auditing (ISA) 810 (Revised), Engagements to Report on Summary Financial Statements.

 

 

Certified Public Accountants (Kenya) 18 March 2021

FCPA Anne Muraya, Practising certificate No. 1697.

Signing partner responsible for the independent audit

 

 

18 March 2021

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FLFIAVTITLIL
12
Date   Source Headline
20th Mar 20248:27 amRNSAnnual Financial Report
6th Dec 20237:00 amRNSProfit Warning Announcement
25th Aug 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSAnnual Financial Report
19th Aug 20227:00 amRNSHalf-year Report
23rd Mar 20227:00 amRNSAnnual Financial Report
6th Jan 20227:00 amRNS2021 PROFIT WARNING ANNOUNCEMENT
18th Aug 20217:00 amRNSHalf-year Report
22nd Mar 20217:00 amRNSAnnual Financial Report - Replacement
19th Mar 20217:00 amRNSAnnual Financial Report
2nd Nov 20207:00 amRNSDirectorate Change
19th Aug 20207:00 amRNSHalf-year Report
26th May 20207:00 amRNSAGM Statement
9th Apr 20207:00 amRNSDividend Declaration
20th Mar 20207:00 amRNSAnnual Financial Report
19th Feb 20207:00 amRNSDeath Of Director
15th Aug 20197:00 amRNSHalf-year Report
29th Mar 20197:00 amRNSAnnual Financial Report
15th Aug 20187:00 amRNSHalf-year Report
23rd Mar 20187:00 amRNSAnnual Financial Report
7th Aug 20177:00 amRNSHalf-year Report
29th Mar 20177:00 amRNSDirectorate Change
29th Mar 20177:00 amRNSAnnual Financial Report
3rd Aug 20167:00 amRNSDirectorate Change
3rd Aug 20167:00 amRNSHalf-year Report
17th Mar 20167:00 amRNSAnnual Financial Report
12th Aug 20157:00 amRNSHalf Yearly Report
27th May 20157:00 amRNSDirectorate Change
25th Mar 20157:00 amRNSAnnual Financial Report
27th Aug 20147:00 amRNSHalf Yearly Report
19th Mar 20147:00 amRNSFinal Results
27th Nov 20137:00 amRNSPROFIT WARNING
27th Aug 20137:00 amRNSHalf Yearly Report
2nd Apr 20137:00 amRNSDirectorate Change
2nd Apr 20137:00 amRNSAnnual Financial Report
30th Nov 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSProfit Warning Announcement
31st Aug 20127:00 amRNSInterim Financial Statements
22nd Aug 20127:00 amRNSDisposal
2nd Apr 20127:00 amRNSFinal results for the year ended 31 Dec 2011
7th Feb 20127:00 amRNSPublic Announcement
30th Aug 20117:11 amRNSHalf Yearly Report
18th Mar 20118:03 amRNSFinal Results 2010 Replacement
18th Mar 20117:39 amRNSFinal Results 2010
26th Jan 20117:00 amRNSPublic Announcement
25th Aug 20104:55 pmRNSHalf Yearly Report
12th Mar 20107:00 amRNSFinal Results
26th Aug 20097:00 amRNSHalf Yearly Report
5th Mar 20094:21 pmRNSFinal Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.